Species Specific Susceptibility of Malassezia against Antifungal Agents in vitro

被引:1
|
作者
Nenoff, P. [1 ,2 ]
Kalinowska-Pujdak, A. [1 ]
Schmalreck, A. [3 ]
机构
[1] Univ Klinikum Leipzig, Klin Dermatol Venerol & Allergol, Leipzig, Germany
[2] Lab Med Mikrobiol, Molbis, Germany
[3] Mikrobiol Beratung & Serv, Munich, Germany
关键词
D O I
10.1055/s-2006-944857
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Yeasts of the genus Malassezia are part of the normal flora of human skin. Under appropriate conditions they may cause skin infections such as pityriasis versicolor, Malassezia folliculitis, se-borrhoeic dermatitis, and dandruff. It has been reported that Malassezia may be a trigger factor for atopic dermatitis. The in vitro antifungal susceptibility testing of Malassezia still remains a problem. There is no recommended method of antifungal susceptibility testing designed for lipophilic genus Malassezia. 81 strains of Malassezia were examined for their in vitro susceptibility to antifungal substances (17 were reference or pre-identified strains, 64 were obtained from clinical specimens). Identification of the clinical strains based on biochemical features and Fourier-Transform-Infrared-Spectroscopy. All strains were maintained 7 days on modified Dixon agar. In vitro susceptibility testing was performed on microtitration plates with laid out of 6 dehydrated antifungals (ketoconazole, voriconazole, itraconazole, fluconazole, amphotericin B, and 5-flucytosin) in 12 different concentrations. The yeast cell inoculum was adjusted to 5" 103 cfu (colony forming unit) suspended in modified Dixon without peptone. All Malassezia strains were very susceptible to the azole drugs. Especially, voriconazole (MIC - minimum inhibitory concentration -0.007 - 1 mg/ml), itraconazole (MIC 0.007 - 0.05 mg/ml), and ketoconazole (MIC 0.03 - 0.5 mg/ml) were the most effective agents. MIC values among Malassezia sympodialis, Malassezia globosa and Malassezia obtusa were comparable, whereas MIC values for M. furfur were significantly higher (p < 0.05). All values ranged among those accepted according the NCCLS standards. Amphotericin B was also effective against Malassezia in vitro (MIC 0.03125 - 8 mg/ml). 5-Flucytosin was unlikely to inhibit the growth of Malassezia. In some cases it could prevent the growth, however high concentrations were needed. There were variations in susceptibility of different Malassezia species to azole antifungal substances. Malassezia furfur was found to be the less susceptible species when compared to Malassezia obtusa, Malassezia globosa and Malassezia sympodialis.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 50 条
  • [1] In vitro combination of antifungal agents against Malassezia pachydermatis
    Schlemmer, Karine B.
    de Jesus, Francielli P. K.
    Loreto, Erico S.
    Farias, Julia B.
    Alves, Sydney H.
    Ferreiro, Laerte
    Santurio, Janio M.
    [J]. MEDICAL MYCOLOGY, 2019, 57 (03) : 324 - 327
  • [2] Antifungal activities of azole agents against the Malassezia species
    Miranda, Karla Carvalho
    de Araujo, Crystiane Rodrigues
    Costa, Carolina Rodrigues
    Passos, Xisto Sena
    Lisboa Fernandes, Orionalda de Fatima
    Rodrigues Silva, Maria do Rosario
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (03) : 281 - 284
  • [3] In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species
    Javier Carrillo-Munoz, Alfonso
    Rojas, Florencia
    Tur-Tur, Cristina
    de los Angeles Sosa, Maria
    Ortiz Diez, Gustavo
    Martin Espada, Carmen
    Jesus Paya, Maria
    Giusiano, Gustavo
    [J]. MYCOSES, 2013, 56 (05) : 571 - 575
  • [4] Susceptibility profiles of Malassezia species against antifungal drugs of clinical use.
    Rojas, Florencia
    Sosa, Maria
    Mussin, Javier
    Angiolella, Letizia
    Giusiano, Gustavo
    [J]. MEDICAL MYCOLOGY, 2018, 56 : S86 - S86
  • [5] In Vitro Activities of Antifungal Agents Against Rhodotorula Species
    Pelaez, T.
    Gama, B.
    Munoz, P.
    Ruiz-Serrano, M. J.
    Guinea, J.
    Flores, R.
    Pedromingo, M.
    Bouza, E.
    [J]. MYCOSES, 2009, 52 : 36 - 36
  • [6] In vitro Susceptibility of Clinical Aspergillus Species to Some Antifungal Agents
    Bahkali, Ali H.
    Elgorban, Abdallah M.
    El-Samawaty, Abd El-Rahim M. A.
    Almogren, Huda-Mogren A.
    El-Metwally, Mohamed A.
    Al-Harbi, Naif S.
    [J]. INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2015, 11 (05) : 496 - 501
  • [7] Novel sulfamoylbenzoates as antifungal agents against Malassezia furfur
    Trifonov, Lena
    Chumin, Katerina
    Gvirtz, Raanan
    Afri, Michal
    Korshin, Edward E.
    Cohen, Guy
    Gruzman, Arie
    [J]. MENDELEEV COMMUNICATIONS, 2020, 30 (06) : 709 - 711
  • [8] Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species
    Sugita, T
    Tajima, M
    Ito, T
    Saito, M
    Tsuboi, R
    Nishikawa, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (06) : 2824 - 2829
  • [9] In vitro antifungal susceptibility of Malassezia furfur from bloodstream infections
    Latta, Roberta
    Figueredo, Luciana A.
    Montagna, Maria Teresa
    Otranto, Domenico
    Cafarchia, Claudia
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 1467 - 1473
  • [10] In Vitro Interactions of Antifungal Agents and Everolimus Against Aspergillus Species
    Jiang, Huiping
    Xiong, Jianqun
    Tan, Lihua
    Jin, Ping
    Sun, Yi
    Yang, Lianjuan
    Tan, Jingwen
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12